Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 0.0 | 0.0 | 0.0 | 2.4 | 2.6 | 2.2 | 1.2 | 1.0 |
| Revenue growth | | | | -5.7% | 14.7% | 90.2% | 21.3% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 5.6 | 8.3 | 9.7 | 10.1 | 9.6 |
| Gross profit | 0.0 | 0.0 | 0.0 | -3.2 | -5.7 | -7.5 | -8.9 | -8.6 |
| Gross margin | | | | -132.6% | -221.1% | -333.1% | -757.8% | -882.7% |
| Selling, general and administrative | 0.0 | 0.0 | 0.0 | | | | | |
| Research and development | | | | 16.4 | 14.4 | 14.0 | 11.1 | 7.3 |
| General and administrative | 0.0 | 0.0 | 0.0 | 3.9 | 4.4 | 4.2 | 3.6 | 2.2 |
| EBIT | 0.0 | 0.0 | 0.0 | -21.1 | -17.9 | -15.3 | -8.7 | -3.1 |
| EBIT margin | | | | -870.0% | -697.0% | -680.5% | -739.7% | -321.6% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | -19.6 | -17.2 | -14.5 | -8.9 | -2.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Tax rate | | | | | 0.0% | 0.0% | 0.0% | |
| Net income | 0.0 | 0.0 | 0.0 | -19.6 | -17.2 | -14.5 | -8.9 | -2.5 |
| Net margin | | | | -808.3% | -669.5% | -648.1% | -753.0% | -259.5% |
| |
| Diluted EPS | | | | ($0.77) | ($0.68) | ($0.58) | ($0.45) | ($0.14) |
| Shares outstanding (diluted) | | | | 25.4 | 25.3 | 25.1 | 19.7 | 18.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|